ArticleNPJ breast cancer2023

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer.

Melinda Magna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.